Yu, Margaret K.,Yu, Margaret K.,Snyder, Linda Anne
申请号：
AU2018251594
公开号：
AU2018251594A1
申请日:
2018.04.09
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided are methods and compositions, for treating prostate cancer by administering to a patient in need thereof a therapeutically effective amount of a PARP inhibitor, e.g., niraparib； a therapeutically effective amount of a CYP17 inhibitor, e.g., abiraterone acetate, and a therapeutically effective amount of a glucocorticoid, e.g., prednisone.
